Novus Biologicals™ CPT1A Antibody Blocking Peptide

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide from human CPT1A. Source: Synthetic Amino Acid Sequence: C-DPAQTVEQRLKLFK The CPT1A Blocking Peptide is derived from Synthetic. The CPT1A Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 1374
• Protein Family: CPT1A
• Protein Subtype: Blocking Peptide
• Purification Method: Immunogen affinity purified
• Purity: >50%, by HPLC
• Common Name: CPT1A Blocking Peptide
• Concentration: LYOPH
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: Lyophilized from a 5 pmol/ul solution in 5% (v/v) acetonitrile/H₂O and TFA salt.
• For Use With (Application): Antibody Competition
• Gene Alias: carnitine O-palmitoyltransferase 1, liver isoform, Carnitine O-palmitoyltransferase I, liver isoform, Carnitine palmitoyltransferase 1A, carnitine palmitoyltransferase 1A (liver), carnitine palmitoyltransferase I, liver, CPT I, CPT1, CPT1-LEC 2.3.1.21, CPTI-L, EC 2.3.1, L-CPT1
• Gene Symbol: CPT1A
• Label Type: Unlabeled
• Molecular Weight (g/mol): 88kDa
• Product Type: Peptide
• Quantity: 0.1 mg
• Regulatory Status: RUO
• Research Category: Neuroscience
• Source: Goat
• Specific Reactivity: Human
• Immunogen: C-DPAQTVEQRLKLFK